|
J. Biol. Chem., Vol. 261, Issue 16, 7357-7365, 06, 1986
Primary structure of limulus anticoagulant anti-lipopolysaccharide factor
J Aketagawa, T Miyata, S Ohtsubo, T Nakamura, T Morita, H Hayashida, T Miyata, S Iwanaga, T Takao and Y Shimonishi
A potent anticoagulant, anti-lipopolysaccharide (LPS) factor, found in
limulus hemocytes inhibits the LPS-mediated activation of limulus
coagulation cascade and shows an antibacterial action against R-types of
Gram-negative bacteria (Morita, T., Ohtsubo, S., Nakamura, T., Tanaka, S.,
Iwanaga, S., Ohashi, K., and Niwa, M. (1985) J. Biochem. (Tokyo) 97,
1611-1620). The complete amino acid sequence of this substance was
determined by sequencing the peptides obtained by selective proteolytic
cleavage. The NH2-terminal end of anti-LPS factor was pyroglutamic acid.
Anti-LPS factor had two variant residues at position 36 and the
COOH-terminal end, respectively. The following sequence was assigned to
anti-LPS factor, and it was also confirmed by fast atom bombardment mass
spectrometry. less than EGGIWTQLALALVKNLATLWQSGDFQFLGHE (formula; see text)
Limulus anti-LPS factor consisted of a single chain of 102 residues with 2
half-cystines in disulfide linkage. Its NH2-terminal region up to 20
residues was highly hydrophobic, and positively charged residues were
clustered mainly within the disulfide loop. By searching the homologous
sequence in known protein sequences with that of anti-LPS factor, we found
a structural homology between anti-LPS factor and alpha-
lactalbumin/lysozyme family.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Koshiba, T. Hashii, and S.-i. Kawabata
A Structural Perspective on the Interaction between Lipopolysaccharide and Factor C, a Receptor Involved in Recognition of Gram-negative Bacteria
J. Biol. Chem.,
February 9, 2007;
282(6):
3962 - 3967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Armstrong, S. M. Theg, N. Braun, N. Wainwright, R. L. Pardy, and P. B. Armstrong
Histochemical evidence for lipid A (endotoxin) in eukaryote chloroplasts
FASEB J,
October 1, 2006;
20(12):
2145 - 2146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Tincu and S. W. Taylor
Antimicrobial Peptides from Marine Invertebrates
Antimicrob. Agents Chemother.,
October 1, 2004;
48(10):
3645 - 3654.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Armstrong, M. T. Armstrong, R. L. Pardy, A. Child, and N. Wainwright
Immunohistochemical Demonstration of a Lipopolysaccharide in the Cell Wall of a Eukaryote, the Green Alga, Chlorella
Biol. Bull.,
October 1, 2002;
203(2):
203 - 204.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dankesreiter, A. Hoess, J. Schneider-Mergener, H. Wagner, and T. Miethke
Synthetic Endotoxin-Binding Peptides Block Endotoxin- Triggered TNF-{alpha} Production by Macrophages In Vitro and In Vivo and Prevent Endotoxin-Mediated Toxic Shock
J. Immunol.,
May 1, 2000;
164(9):
4804 - 4811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Ridge, E. J. Paus, T. J. Novitsky, and P. A. Ketchum
Reversible binding of heparin to the loop peptide of endotoxin neutralizing protein
Innate Immunity,
February 1, 2000;
6(1):
17 - 23.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Azumi and K.-i. Tanamoto
Anti-endotoxin properties of a cinnamon bark-derived compound and its effect on the endotoxin shock model
Innate Immunity,
June 1, 1999;
5(3):
109 - 117.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A.W.M. Pui, B. Ho, and J.L. Ding
Yeast recombinant Factor C from horseshoe crab binds endotoxin and causes bacteriostasis
Innate Immunity,
December 1, 1997;
4(6):
391 - 400.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ried, C. Wahl, T. Miethke, G. Wellnhofer, C. Landgraf, J. Schneider-Mergener, and A. Hoess
High Affinity Endotoxin-binding and Neutralizing Peptides Based on the Crystal Structure of Recombinant Limulus Anti-lipopolysaccharide Factor
J. Biol. Chem.,
November 8, 1996;
271(45):
28120 - 28127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Agarwala, S.-i. Kawabata, Y. Miura, Y. Kuroki, and S. Iwanaga
Limulus Intracellular Coagulation Inhibitor Type 3. PURIFICATION, CHARACTERIZATION, cDNA CLONING, AND TISSUE LOCALIZATION
J. Biol. Chem.,
September 27, 1996;
271(39):
23768 - 23774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Fletcher, M. Kloczewiak, P. M. Loiselle, S. F. Amato, K. M. Black, and H. S. Warren
TALF peptide-immunoglobulin G conjugates that bind lipopolysaccharide
Innate Immunity,
February 1, 1996;
3(1):
49 - 55.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Saito, S.-i. Kawabata, M. Hirata, and S. Iwanaga
A Novel Type of limulus Lectin-L6
J. Biol. Chem.,
June 16, 1995;
270(24):
14493 - 14499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miura, S.-i. Kawabata, Y. Wakamiya, T. Nakamura, and S. Iwanaga
A Limulus Intracellular Coagulation Inhibitor Type 2
J. Biol. Chem.,
January 13, 1995;
270(2):
558 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Muta, N. Seki, Y. Takaki, R. Hashimoto, T. Oda, A. Iwanaga, F. Tokunaga, and S. Iwanaga
Purified Horseshoe Crab Factor G
J. Biol. Chem.,
January 13, 1995;
270(2):
892 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|